Movatterモバイル変換
[0]
ホーム
URL:
画像なし
夜間モード
Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Community portal
Project chat
Create a new Item
Recent changes
Random Item
Query Service
Nearby
Help
Special pages
Lexicographical data
Create a new Lexeme
Recent changes
Random Lexeme
Search
Search
English
Appearance
Donate
Create account
Log in
Personal tools
Donate
Create account
Log in
carbamazepin
(Q410412)
Item
Discussion
English
Read
View history
Tools
Tools
move to sidebar
hide
Actions
Read
View history
General
What links here
Related changes
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Concept URI
Print/export
Create a book
Download as PDF
Printable version
In other projects
Appearance
move to sidebar
hide
From Wikidata
anticonvulsant medication
TEG111
5-carbamoyl-5H-dibenz[b,f]azepine
CBZ
5H-dibenz[b,f]azepine-5-carboxamide
5-carbamyl-5H-dibenzo[b,f]azepine
5-carbamoyl-5H-dibenzo[b,f]azepine
edit
Language
Label
Description
Also known as
default for all languages
No label defined
–
English
carbamazepin
anticonvulsant medication
TEG111
5-carbamoyl-5H-dibenz[b,f]azepine
CBZ
5H-dibenz[b,f]azepine-5-carboxamide
5-carbamyl-5H-dibenzo[b,f]azepine
5-carbamoyl-5H-dibenzo[b,f]azepine
Statements
instance of
type of chemical entity
0 references
subclass of
chemical compound
0 references
has use
medication
0 references
chemical structure
Carbamazepine.svg
512 × 378; 4 KB
1 reference
imported from Wikimedia project
German Wikipedia
stylized name
carBAMazepine
has characteristic
Tall Man lettering
issued by
Institute for Safe Medication Practices
1 reference
reference URL
https://www.ismp.org/recommendations/tall-man-letters-list
retrieved
2 September 2022
TEGretol
has characteristic
Tall Man lettering
issued by
Institute for Safe Medication Practices
1 reference
reference URL
https://www.ismp.org/recommendations/tall-man-letters-list
retrieved
2 September 2022
has effect
carbamazepine allergy
0 references
chemical formula
C₁₅H₁₂N₂O
1 reference
stated in
PubChem
PubChem CID
2554
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
canonical SMILES
C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N
1 reference
stated in
PubChem
PubChem CID
2554
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
melting point
191.5
degree Celsius
1 reference
stated in
Jean-Claude Bradley Open Melting Point Dataset
active ingredient in
Carnexiv
1 reference
stated in
RxNorm
RxNorm CUI
1813509
retrieved
14 February 2018
Tegretol
1 reference
stated in
RxNorm
RxNorm CUI
203029
retrieved
14 February 2018
Carbatrol
1 reference
stated in
RxNorm
RxNorm CUI
215879
retrieved
14 February 2018
Equetro
1 reference
stated in
RxNorm
RxNorm CUI
583135
retrieved
14 February 2018
World Health Organisation international non-proprietary name
carbamazepine
(English)
2 references
stated in
ChEBI
ChEBI ID
3387
language of work or name
English
title
carbamazepine
(English)
retrieved
3 October 2016
published in
Recommended INN: List 6
publication date
1966
medical condition treated
trigeminal neuralgia
2 references
stated in
NDF-RT
NDF-RT ID
N0000146226
language of work or name
English
retrieved
13 December 2016
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
tonic–clonic seizure
1 reference
stated in
NDF-RT
NDF-RT ID
N0000146226
language of work or name
English
retrieved
13 December 2016
bipolar disorder
1 reference
stated in
NDF-RT
NDF-RT ID
N0000146226
language of work or name
English
retrieved
13 December 2016
complex partial seizure
1 reference
stated in
NDF-RT
NDF-RT ID
N0000146226
language of work or name
English
retrieved
13 December 2016
restless legs syndrome
1 reference
stated in
NDF-RT
NDF-RT ID
N0000146226
language of work or name
English
retrieved
13 December 2016
schizophrenia
1 reference
stated in
NDF-RT
NDF-RT ID
N0000146226
language of work or name
English
retrieved
13 December 2016
post-traumatic stress disorder
1 reference
stated in
NDF-RT
NDF-RT ID
N0000146226
language of work or name
English
retrieved
13 December 2016
temporal lobe epilepsy
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
epilepsy
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
mood disorder
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
trigeminal neuralgia
start time
11 March 1968
approved by
Food and Drug Administration
1 reference
stated in
Inxight: Drugs Database
retrieved
2 November 2018
reference URL
https://drugs.ncats.io/drug/33CM23913M
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053
epilepsy
start time
11 March 1968
approved by
Food and Drug Administration
1 reference
stated in
Inxight: Drugs Database
retrieved
2 November 2018
reference URL
https://drugs.ncats.io/drug/33CM23913M
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053
significant drug interaction
desmopressin
side effect
hyponatremia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
furosemide
side effect
hyponatremia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
hydrochlorothiazide
side effect
hyponatremia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
sertraline
side effect
hyponatremia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
fluvoxamine
side effect
hyponatremia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
fluoxetine
side effect
hyponatremia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
vincristine
side effect
hepatotoxicity
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
simvastatin
side effect
hepatotoxicity
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
itraconazole
side effect
hepatotoxicity
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
doxycycline
side effect
hepatotoxicity
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
fluconazole
side effect
hepatotoxicity
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
isoniazid
side effect
hepatotoxicity
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
L-thyroxine
side effect
hypothyroidism
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
procarbazine
side effect
hypersensitivity
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
lithium
side effect
toxic encephalopathy
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
clozapine
side effect
bone marrow failure
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
procarbazine
side effect
geniospasm
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
procarbazine
side effect
mental status change
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
procarbazine
side effect
hyperthermia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
procarbazine
side effect
hypertension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
rac-warfarin
side effect
short coagulation time
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
bazedoxifene
side effect
endometrial hyperplasia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
cobicistat
1 reference
sourcing circumstances
established
stated in
A reference set of clinically relevant adverse drug-drug interactions
danazol
side effect
seizure
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
danazol
side effect
nystagmus
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
danazol
side effect
ataxia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
danazol
side effect
monocular diplopia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
danazol
side effect
headache disorder
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
danazol
side effect
vomiting
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
danazol
side effect
apnea
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
danazol
side effect
coma
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
legal status (medicine)
boxed warning
1 reference
reference URL
https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
title
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.
(English)
pregnancy category
Australian pregnancy category D
1 reference
imported from Wikimedia project
English Wikipedia
US pregnancy category D
1 reference
imported from Wikimedia project
English Wikipedia
LiverTox likelihood score
LiverTox toxicity likelihood category A
1 reference
stated in
LiverTox
retrieved
8 April 2021
reference URL
https://www.ncbi.nlm.nih.gov/books/n/livertox/Carbamazepine
last update
15 January 2017
mass
236.094963
dalton
1 reference
stated in
PubChem
PubChem CID
2554
language of work or name
English
title
carbamazepine
(English)
retrieved
3 October 2016
subject has role
non-opioid analgesic
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D002220
retrieved
15 March 2018
anticonvulsant agent
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D002220
retrieved
15 March 2018
cytochrome P-450 CYP3A inducers
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D002220
retrieved
15 March 2018
antimanic agents
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D002220
retrieved
15 March 2018
essential medicine
0 references
developmental toxicant
start time
29 January 1999
1 reference
stated in
California Proposition 65 list of chemicals
retrieved
21 February 2020
reference URL
https://oehha.ca.gov/chemicals/carbamazepine
MCN code
2933.99.32
0 references
different from
diethylcarbamazine
1 reference
imported from Wikimedia project
English Wikipedia
Wikimedia import URL
https://en.wikipedia.org/w/index.php?title=Carbamazepine&oldid=950548476
Commons category
Carbamazepine
0 references
Identifiers
National Library of Israel J9U ID
987007283337605171
subject named as
קרבמזפין
Carbamazepine
0 references
Library of Congress authority ID
sh85020070
0 references
InChI
InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)
1 reference
stated in
PubChem
PubChem CID
2554
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
InChIKey
FFGPTBGBLSHEPO-UHFFFAOYSA-N
2 references
stated in
PubChem
PubChem CID
2554
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
stated in
ChEBI release 2020-09-01
CAS Registry Number
298-46-4
2 references
stated in
Global Substance Registration System
UNII
33CM23913M
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
InChIKey
FFGPTBGBLSHEPO-UHFFFAOYSA-N
stated in
CAS Common Chemistry
retrieved
9 April 2021
reference URL
https://commonchemistry.cas.org/detail?cas_rn=298-46-4
ChemSpider ID
2457
1 reference
stated in
ChemSpider
ChemSpider ID
2457
language of work or name
English
title
Carbamazepine
(English)
retrieved
18 November 2016
PubChem CID
2554
2 references
stated in
PubChem
PubChem CID
2554
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
matched by identifier from
InChIKey
InChIKey
FFGPTBGBLSHEPO-UHFFFAOYSA-N
Reaxys registry number
1246090
1 reference
stated in
ChEBI
ChEBI ID
3387
language of work or name
English
title
carbamazepine
(English)
retrieved
3 October 2016
ChEBI ID
3387
mapping relation type
exact match
2 references
stated in
ChEMBL
ChEMBL ID
CHEMBL108
language of work or name
English
title
CARBAMAZEPINE
(English)
retrieved
18 November 2016
matched by identifier from
International Chemical Identifier
InChI
InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)
ChEMBL ID
CHEMBL108
1 reference
stated in
ChEMBL
ChEMBL ID
CHEMBL108
language of work or name
English
title
CARBAMAZEPINE
(English)
retrieved
18 November 2016
SureChEMBL ID
21639
2 references
based on heuristic
inferred from InChIKey
matched by identifier from
InChIKey
InChIKey
FFGPTBGBLSHEPO-UHFFFAOYSA-N
UniChem compound ID
438145
1 reference
stated in
UniChem
CCDC Number
1121421
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
1121422
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
1121423
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
1121424
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
185919
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
249934
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
CSD Refcode
CBMZPN01
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
CBMZPN02
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
CBMZPN03
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
CBMZPN10
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
CBMZPN11
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
CBMZPN12
1 reference
stated in
Cambridge Structural Database
retrieved
10 January 2023
based on heuristic
InChIKey match
MassBank accession ID
MSBNK-Athens_Univ-AU112001
0 references
MSBNK-Athens_Univ-AU112002
0 references
MSBNK-Athens_Univ-AU112003
0 references
MSBNK-Athens_Univ-AU112004
0 references
MSBNK-Athens_Univ-AU112005
0 references
MSBNK-Eawag-EA019401
0 references
MSBNK-Eawag-EA019402
0 references
MSBNK-Eawag-EA019403
0 references
MSBNK-Eawag-EA019404
0 references
MSBNK-Eawag-EA019405
0 references
MSBNK-Eawag-EA019406
0 references
MSBNK-Eawag-EA019407
0 references
MSBNK-Eawag-EA019408
0 references
MSBNK-Eawag-EA019409
0 references
MSBNK-Eawag-EA019410
0 references
MSBNK-Eawag-EA019411
0 references
MSBNK-Eawag-EA019412
0 references
MSBNK-Eawag-EA019413
0 references
MSBNK-Eawag-EA019414
0 references
MSBNK-UFZ-UA003001
0 references
MSBNK-UFZ-UA003003
0 references
MSBNK-Waters-WA001146
0 references
MSBNK-Waters-WA001147
0 references
MSBNK-Waters-WA001148
0 references
MSBNK-Waters-WA001149
0 references
MSBNK-Waters-WA001150
0 references
SPLASH
splash10-0006-0910000000-f171a56d3bbeaef24ff4
0 references
splash10-0006-0900000000-a82def037961e9b94a9a
0 references
splash10-0006-0900000000-484ce005b4ae5d01fc2a
0 references
splash10-0006-0900000000-a6992953eac16c120e74
0 references
splash10-0006-0900000000-7a1010be5231131649eb
0 references
splash10-000i-0090000000-51ef94c86cca9b541780
0 references
splash10-000i-0490000000-4484ac1671912bc60ba9
0 references
splash10-0006-0910000000-e5ca06888593ada95f15
0 references
splash10-0006-0900000000-5742023f1e263fb40066
0 references
splash10-0006-0900000000-f27fb9d17b228cc328b8
0 references
splash10-0006-0900000000-63c554c485fd1d117082
0 references
splash10-000i-0090000000-c6c89d3e663885fcc080
0 references
splash10-000i-0490000000-8a1d8d7b932f1b0ad45e
0 references
splash10-0006-0910000000-843efaf5294cb110e0b9
0 references
splash10-0006-0900000000-7eb2855f73a1ed729181
0 references
splash10-0006-0900000000-8a4709b0e827021ff3f9
0 references
splash10-0006-0900000000-1df850c9bb30bdd7c2e8
0 references
splash10-0006-0900000000-13a692d2c13ee8b68c2b
0 references
splash10-0006-0900000000-83772c2db35186bf1ecc
0 references
splash10-0006-0900000000-b290173294be98d66006
0 references
splash10-0006-0910000000-19e4159c1f593ac5b7d2
0 references
splash10-0006-0900000000-771ef8e73ddaa54860b8
0 references
splash10-0006-0900000000-1f2ce6522abf287f6ebe
0 references
splash10-0006-0900000000-09a5be76975259b856bc
0 references
splash10-000l-0790000000-3f156da840f13ea32859
0 references
splash10-000l-0790000000-e267c61a115cced80f60
0 references
splash10-000f-1940000000-9677ddf985ba43e76817
0 references
splash10-0006-0900000000-ff23826da10bdf95f991
0 references
splash10-0006-0900000000-25b86b23833bee39c759
0 references
splash10-0006-1910000000-4b2dc85e8da73b101ed2
0 references
ZVG number
530495
0 references
HSDB ID
3019
1 reference
stated in
Hazardous Substances Data Bank
HSDB ID
3019
publication date
28 October 2019
title
CARBAMAZEPINE
(English)
retrieved
10 May 2021
DSSTox substance ID
DTXSID4022731
2 references
stated in
Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
matched by identifier from
InChIKey
InChIKey
FFGPTBGBLSHEPO-UHFFFAOYSA-N
DSSTOX compound identifier
DTXCID902731
0 references
LiverTox ID
Carbamazepine
0 references
NSC number
169864
0 references
755920
0 references
EC number
206-062-7
1 reference
stated in
Global Substance Registration System
UNII
33CM23913M
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
ECHA Substance Infocard ID
100.005.512
1 reference
stated in
ECHA Substance Infocard database
ECHA Substance Infocard ID
100.005.512
retrieved
27 December 2018
title
Carbamazepine
(English)
quotation
CAS no.: 298-46-4
(English)
ATC code
N03AF01
1 reference
stated in
DrugBank
DrugBank ID
DB00564
language of work or name
English
title
Carbamazepine
(English)
publication date
17 November 2015
World Health Organisation international non-proprietary name numeric ID
1836
1 reference
reference URL
https://mednet-communities.net/inn/db/ViewINN.aspx?i=1836
Guide to Pharmacology Ligand ID
5339
1 reference
stated in
IUPHAR/BPS Guide to PHARMACOLOGY
Guide to Pharmacology Ligand ID
5339
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
MeSH descriptor ID
D002220
subject named as
Carbamazepine
0 references
MeSH concept ID
M0003328
0 references
MeSH tree code
D03.633.300.240.127
broader concept
dibenzazepine
0 references
RxNorm CUI
2002
1 reference
stated in
Global Substance Registration System
UNII
33CM23913M
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
DrugBank ID
DB00564
1 reference
matched by identifier from
InChIKey
InChIKey
FFGPTBGBLSHEPO-UHFFFAOYSA-N
Human Metabolome Database ID
HMDB0014704
2 references
based on heuristic
inferred from InChIKey
matched by identifier from
InChIKey
InChIKey
FFGPTBGBLSHEPO-UHFFFAOYSA-N
UNII
33CM23913M
2 references
stated in
Global Substance Registration System
UNII
33CM23913M
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
matched by identifier from
InChIKey
InChIKey
FFGPTBGBLSHEPO-UHFFFAOYSA-N
MedlinePlus drug identifier
a682237
0 references
PatientsLikeMe treatment ID
carbamazepine
0 references
NDF-RT ID
N0000146226
1 reference
stated in
Global Substance Registration System
UNII
33CM23913M
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
Probes And Drugs ID
PD002445
0 references
DrugCentral ID
489
1 reference
stated in
UniChem
KEGG ID
C06868
1 reference
stated in
ChEBI
ChEBI ID
3387
language of work or name
English
title
carbamazepine
(English)
retrieved
3 October 2016
D00252
1 reference
stated in
ChEBI
ChEBI ID
3387
language of work or name
English
title
carbamazepine
(English)
retrieved
3 October 2016
IEDB Epitope ID
174842
1 reference
stated in
Immune Epitope Database and Analysis Resource
IEDB Epitope ID
174842
retrieved
1 March 2022
PDB ligand ID
N6W
0 references
BNCF Thesaurus ID
71519
0 references
CA PROP 65 ID
carbamazepine
1 reference
stated in
California Proposition 65 list of chemicals
retrieved
2 December 2019
reference URL
https://oehha.ca.gov/chemicals/carbamazepine
DeCS ID
2256
0 references
Encyclopædia Britannica Online ID
science/carbamazepine
subject named as
carbamazepine
0 references
Freebase ID
/m/01_y8
1 reference
stated in
Freebase Data Dumps
publication date
28 October 2013
Gran Enciclopèdia Catalana ID
carbamazepina
0 references
Gran Enciclopèdia Catalana ID (former scheme)
0088484
0 references
KBpedia ID
Carbamazepine
1 reference
stated in
KBpedia
retrieved
9 July 2020
Microsoft Academic ID
2779253243
0 references
OpenAlex ID
C2779253243
1 reference
stated in
OpenAlex
retrieved
26 January 2022
reference URL
https://docs.openalex.org/download-snapshot/snapshot-data-format
UK Parliament thesaurus ID
509998
subject named as
Carbamazepine
0 references
UMLS CUI
C0006949
1 reference
stated in
Global Substance Registration System
UNII
33CM23913M
language of work or name
English
title
carbamazepine
(English)
retrieved
18 November 2016
WikiProjectMed ID
Carbamazepine
0 references
Yale LUX ID
concept/18c33cae-8e27-4079-b4cc-a469286852ea
0 references
YSO ID
27608
subject named as
karbamatsepiini
karbamazepin
carbamazepine
1 reference
stated in
YSO-Wikidata mapping project
retrieved
2 February 2022
Sitelinks
Wikipedia
(43 entries)
edit
arwiki
كاربامازيبين
cawiki
Carbamazepina
cywiki
Carbamasepin
dewiki
Carbamazepin
elwiki
Καρβαμαζεπίνη
enwiki
Carbamazepine
eowiki
Karbamazepino
eswiki
Carbamazepina
euwiki
Karbamazepina
fawiki
کاربامازپین
fiwiki
Karbamatsepiini
frwiki
Carbamazépine
hewiki
קארבאמזפין
hrwiki
Karbamazepin
huwiki
Karbamazepin
hywiki
Կարբամազեպին
idwiki
Karbamazepin
itwiki
Carbamazepina
jawiki
カルバマゼピン
kkwiki
Карбамазепин
kowiki
카르바마제핀
lawiki
Carbamazepinum
minwiki
Karbamazepin
mkwiki
Карбамазепин
nlwiki
Carbamazepine
nowiki
Karbamazepin
orwiki
କାର୍ବାମାଜେପିନ
plwiki
Karbamazepina
ptwiki
Carbamazepina
rowiki
Carbamazepină
ruwiki
Карбамазепин
shwiki
Karbamazepin
slwiki
Karbamazepin
srwiki
Karbamazepin
suwiki
Karbamazepin
svwiki
Karbamazepin
thwiki
คาร์บามาเซพีน
trwiki
Karbamazepin
ukwiki
Карбамазепін
uzwiki
Carbamazepine
viwiki
Carbamazepine
wuuwiki
卡马西平
zhwiki
卡马西平
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(1 entry)
edit
commonswiki
Category:Carbamazepine
Retrieved from "
https://www.wikidata.org/w/index.php?title=Q410412&oldid=2425328317
"
Search
Search
carbamazepin
(Q410412)
Add topic
[8]
ページ先頭
©2009-2025
Movatter.jp
